Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (41)
  • Allergen immunotherapy (81)
  • AllergoOncology (15)
  • Allergy asthma and a sport (4)
  • x Allergy diagnosis (235)
  • Allied health and primary care (20)
  • Anaphylaxis (113)
  • Artificial Intelligence (12)
  • x Asthma (185)
  • Basic immunology (58)
  • Biologicals (90)
  • Biomarkers (64)
  • Comparative veterinary allergology (1)
  • COVID19 (11)
  • Dermatology (125)
  • Drug allergy (172)
  • ENT (29)
  • Environmental allergy and climate change (31)
  • Eosinophilic esophagitis (21)
  • Epidemiology (66)
  • Epithelial cell biology (8)
  • Food allergy (195)
  • Genomics and proteomics (17)
  • Immune deficiencies and autoimmunity (80)
  • Immunomodulation and nutrition (13)
  • Infections (27)
  • Insect venom hypersensitivities (19)
  • Mastocytosis and mast cells (24)
  • Microbiome (9)
  • Occupational allergy (27)
  • Ocular allergy (5)
  • One Health (13)
  • Pediatrics (144)
  • Prevention (40)
  • Systems medicine (13)
Poster available until
  • Until platform closure (27)
Poster categories
  • e-Thematic Poster Session (42)
  • Thematic Poster Session (306)
keywords
Session Reference
  • L-TPS01 (11)
  • L-TPS02 (14)
  • L-TPS05 (1)
  • L-TPS09 (13)
  • L-TPS10 (12)
  • L-TPS14 (11)
  • L-TPS15 (7)
  • L-TPS16 (14)
  • L-TPS18 (3)
  • L-TPS19 (1)
  • TPS01 (12)
  • TPS02 (8)
  • TPS03 (13)
  • TPS04 (1)
  • TPS05 (13)
  • TPS06 (9)
  • TPS07 (11)
  • TPS08 (8)
  • TPS09 (4)
  • TPS19 (1)
  • TPS25 (12)
  • TPS26 (14)
  • TPS27 (12)
  • TPS28 (16)
  • TPS29 (15)
  • TPS30 (11)
  • TPS31 (15)
  • TPS34 (1)
  • TPS38 (1)
  • TPS45 (1)
  • TPS46 (1)
  • TPS51 (12)
  • TPS52 (14)
  • TPS53 (8)
  • TPS54 (15)
  • TPS55 (13)
  • TPS56 (16)
  • TPS57 (12)
  • TPS69 (1)
399 results
Thumbnail

D3.18 - Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population

Thumbnail

D3.19 - Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years

Thumbnail

D3.20 - Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media

Thumbnail

D3.203 - Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts

Thumbnail

D3.205 - Online Education Increases Clinician Knowledge and Confidence in Utilizing Allergen Immunotherapy for Respiratory Allergic Disease

Thumbnail

D3.22 - Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool

Thumbnail

D3.23 - Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre

Thumbnail

D3.26 - Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis

Thumbnail

D3.28 - Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria

Thumbnail

D3.29 - Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients

Thumbnail

D3.30 - Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study

Thumbnail

D3.31 - Successful Management of Primary Cold Urticaria in Medical Practitioners: A Small Case Series

Thumbnail

D3.33 - Severe Eosinophilic Esophagitis: the Key Role of Biologics in Disease Management

Thumbnail

D3.47 - Implementing Penicillin Delabelling in an Inpatient setting

Thumbnail

D3.49 - Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study

Thumbnail

D3.50 - Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists

Thumbnail

D3.51 - Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists

Thumbnail

D3.54 - Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?

Thumbnail

D3.56 - Relevant Aspects in the Investigation of Hypersensitivity Reactions to Non-Beta-Lactam Antibiotics

Thumbnail

D3.57 - Isoniazid-Induced Lupus in a Filipino Female: A Case Report

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM